XML 33 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Schedule of Net Income for Purposes of Determining Basic and Diluted EPS for Discontinued Operations and Net Income Available to Common Stockholders Net income for purposes of determining basic and diluted EPS applicable to common shares was as follows:
Three Months Ended
March 31,
20232022
Net income$34,741 $32,542 
Income attributable to participating securities(930)(983)
Net income available to common stockholders$33,811 $31,559 
Schedule of Basic and Diluted EPS Continuing and Discontinued Operations Calculation Shares
Basic and diluted EPS were calculated using the following common shares:
Three Months Ended
March 31,
20232022
Weighted-average shares for basic EPS153,012,937 152,586,900 
Incremental shares related to stock options and non-vested restricted stock147,499 158,353 
Weighted-average shares for diluted EPS153,160,436 152,745,253 
Schedule of Outstanding Shares Not Included in the Computation of Diluted EPS
The following non-vested restricted stock were outstanding during the three months ended March 31, 2023 and 2022 and were not included in the computation of diluted EPS because the impact of the per share expense associated with the stock options and the restricted stock was greater than the average market price of the common shares during the respective periods.
Three Months Ended
March 31,
20232022
  Weighted-average shares of non-vested restricted stock366,667 — 
  Weighted-average expense per share$12.90 $— 
Schedule of Other, Net
Other, net consisted of:
Three Months Ended
March 31,
20232022
Interest and dividend income$3,935 $450 
Net losses recognized on investment securities(6)(3,039)
Net periodic benefit cost other than the service costs(339)(236)
Other income30 1,680 
Other, net$3,620 $(1,145)
Schedule of Other Assets
Other assets consisted of:
March 31,
2023
December 31, 2022
Restricted assets$26,178 $25,907 
Prepaid pension costs38,717 38,100 
Other assets31,656 31,310 
Total other assets$96,551 $95,317 
Schedule of Other Current Liabilities
Other current liabilities consisted of:
March 31,
2023
December 31, 2022
Accounts payable$5,542 $6,351 
Accrued promotional expenses54,244 56,645 
Accrued excise and payroll taxes payable, net23,574 17,160 
Accrued interest31,812 30,451 
Accrued salaries and benefits3,263 9,614 
Allowance for sales returns9,084 7,526 
Other current liabilities11,538 7,423 
Total other current liabilities$139,057 $135,170 
Schedule of Cash and Cash Equivalents
The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:
March 31,
2023
December 31,
2022
Cash and cash equivalents
$281,868 $224,580 
Restricted cash and cash equivalents included in other assets26,065 25,794 
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows
$307,933 $250,374 
Schedule of Restricted Cash
The components of “Cash, cash equivalents and restricted cash” in the condensed consolidated statements of cash flows were as follows:
March 31,
2023
December 31,
2022
Cash and cash equivalents
$281,868 $224,580 
Restricted cash and cash equivalents included in other assets26,065 25,794 
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows
$307,933 $250,374